Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Lupi

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
American Journal of Cancer Research|February 14, 2025
Tumor Treating Fields enhance chemotherapy efficacy by increasing cellular drug uptake and retention in mesothelioma cellsRosy Amodeo, Lavinia Morosi, Marina Meroni, et al.
Oncotarget|October 7, 2015
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736Valentina Restelli, Rosaria Chilà, Monica Lupi, et al.
Brain Research. Molecular Brain Research|August 30, 2005
Tetracycline-regulated gene expression in the NSC-34-tTA cell line for investigation of motor neuron diseasesElisabetta Babetto, Alessandra Mangolini, Milena Rizzardini, et al.
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivoLaura Carrassa, Rosaria Chilà, Monica Lupi, et al.
Cells|July 29, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine ExploitationElisa Caiola, Marika Colombo, Giovanna Sestito, et al.
Oncotarget|August 31, 2015
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2Carmen Ghilardi, Antonietta Silini, Sara Figini, et al.
Nanotechnology|February 19, 2016
Small interfering RNA delivery through positively charged polymer nanoparticlesLuca Dragoni, Raffaele Ferrari, Monica Lupi, et al.
International Journal of Pharmaceutics|June 26, 2013
Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kineticsRaffaele Ferrari, Claudio Colombo, Cristina Casali, et al.
Journal of Pharmaceutical Analysis|March 24, 2025
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imagingLavinia Morosi, Sara Timo, Rosy Amodeo, et al.
Molecular Cancer Therapeutics|May 9, 2019
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell LymphomasValentina Restelli, Monica Lupi, Rosaria Chilà, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
American Journal of Cancer Research|February 14, 2025
Tumor Treating Fields enhance chemotherapy efficacy by increasing cellular drug uptake and retention in mesothelioma cellsRosy Amodeo, Lavinia Morosi, Marina Meroni, et al.
Oncotarget|October 7, 2015
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736Valentina Restelli, Rosaria Chilà, Monica Lupi, et al.
Brain Research. Molecular Brain Research|August 30, 2005
Tetracycline-regulated gene expression in the NSC-34-tTA cell line for investigation of motor neuron diseasesElisabetta Babetto, Alessandra Mangolini, Milena Rizzardini, et al.
Cell Cycle (Georgetown, Tex.)|June 21, 2012
Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivoLaura Carrassa, Rosaria Chilà, Monica Lupi, et al.
Cells|July 29, 2020
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine ExploitationElisa Caiola, Marika Colombo, Giovanna Sestito, et al.
Oncotarget|August 31, 2015
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2Carmen Ghilardi, Antonietta Silini, Sara Figini, et al.
Nanotechnology|February 19, 2016
Small interfering RNA delivery through positively charged polymer nanoparticlesLuca Dragoni, Raffaele Ferrari, Monica Lupi, et al.
International Journal of Pharmaceutics|June 26, 2013
Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kineticsRaffaele Ferrari, Claudio Colombo, Cristina Casali, et al.
Journal of Pharmaceutical Analysis|March 24, 2025
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imagingLavinia Morosi, Sara Timo, Rosy Amodeo, et al.
Molecular Cancer Therapeutics|May 9, 2019
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell LymphomasValentina Restelli, Monica Lupi, Rosaria Chilà, et al.
Pageof 6